Article info

Extended report
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

Authors

  1. Correspondence to Dr Gerd R Burmester,  Charité—University Medicine Berlin, Free University and Humboldt University Berlin, Charitéplatz 1, Berlin 10117, Germany; Gerd.Burmester{at}charite.de
View Full Text

Citation

Burmester GR, Weinblatt ME, McInnes IB, et al
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

Publication history

  • Accepted October 20, 2012
  • First published December 12, 2012.
Online issue publication 
August 06, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

  • Lay summary

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.